Last reviewed · How we verify

NCT07121738: HEAL-GYN

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

Recruiting now NA Last updated 3 March 2026
What this trial tests

NA trial testing Healthy Eating Active Lifestyle (HEAL): Gyn Cancer Program in Gynecologic Cancers in 64 participants. Currently enrolling.

Timeline
8 December 2025
Primary endpoint
31 August 2026
31 August 2026

Quick facts

Lead sponsorAdventHealth
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment64
Start date8 December 2025
Primary completion31 August 2026
Estimated completion31 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

AdventHealth — full company profile →

Who can join

18 and older, female only, with Gynecologic Cancers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gynecologic Cancers

Currently open trials in the same condition.

Other AdventHealth trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07121738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing